{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["immunopharmacology", "immunotoxicology", "infection", "inflammation", "pharmacoepidemiology"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "34811895", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "19"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "12", "Day": "02"}], "ELocationID": ["10.1111/bcpt.13690"], "Journal": {"ISSN": "1742-7843", "JournalIssue": {"Volume": "130", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Feb"}}, "Title": "Basic & clinical pharmacology & toxicology", "ISOAbbreviation": "Basic Clin Pharmacol Toxicol"}, "ArticleTitle": "Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal.", "Pagination": {"StartPage": "225", "EndPage": "239", "MedlinePgn": "225-239"}, "Abstract": {"AbstractText": ["The COVID-19 pandemic is a highly dramatic concern for mankind. In Italy, the pandemic exerted its major impact throughout the period of February to June 2020. To date, the awkward amount of more than 134,000 deaths has been reported. Yet, post-mortem autopsy was performed on a very modest number of patients who died from COVID-19 infection, leading to a first confirmation of an immune-thrombosis of the lungs as the major COVID-19 pathogenesis, likewise for SARS. Since then (June-August 2020), no targeted early therapy considering this pathogenetic issue was approached. The patients treated with early anti-inflammatory, anti-platelet, anticoagulant and antibiotic therapy confirmed that COVID-19 was an endothelial inflammation with immuno-thrombosis. Patients not treated or scarcely treated with the most proper and appropriate therapy and in the earliest, increased the hospitalization rate in the intensive care units and also mortality, due to immune-thrombosis from the pulmonary capillary district and alveoli. The disease causes widespread endothelial inflammation, which can induce damage to various organs and systems. Therapy must be targeted in this consideration, and in this review, we demonstrate how early anti-inflammatory therapy may treat endothelia inflammation and immune-thrombosis caused by COVID-19, by using drugs we are going to recommend in this paper."], "CopyrightInformation": "\u00a9 2021 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society). Published by John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "High School of Oxygen Ozone Therapy, University of Pavia, Pavia, Italy."}, {"Identifier": [], "Affiliation": "Unit of Neurosurgery, Villa Mafalda Health Clinics, Rome, Italy."}], "LastName": "Pandolfi", "ForeName": "Sergio", "Initials": "S"}, {"Identifier": ["0000-0003-1789-8307"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy."}], "LastName": "Chirumbolo", "ForeName": "Salvatore", "Initials": "S"}, {"Identifier": ["0000-0003-3422-2747"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Science, University of Pavia, Pavia, Italy."}], "LastName": "Ricevuti", "ForeName": "Giovanni", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "High School of Oxygen Ozone Therapy, University of Pavia, Pavia, Italy."}], "LastName": "Valdenassi", "ForeName": "Luigi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Direction Board, Council for Nutritional an Environmental Medicine (CONEM), Mo i Rana, Norway."}], "LastName": "Bj\u00f8rklund", "ForeName": "Geir", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CONEM Ukraine Life Science Research Group, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine."}], "LastName": "Lysiuk", "ForeName": "Roman", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Ovidius University, Constanta, Romania."}], "LastName": "Do\u015fa", "ForeName": "Monica Daniela", "Initials": "MD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CONEM Ukraine Pharmacognosy and Natural Product Chemistry Research Group, National University of Pharmacy, Kharkiv, Ukraine."}], "LastName": "Lenchyk", "ForeName": "Larysa", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Naples Federico II, Naples, Italy."}], "LastName": "Fazio", "ForeName": "Serafino", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Basic Clin Pharmacol Toxicol", "NlmUniqueID": "101208422", "ISSNLinking": "1742-7835"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anticoagulants"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Platelet Aggregation Inhibitors"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anticoagulants"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["diagnosis", "mortality", "virology"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Clinical Decision-Making"}, {"QualifierName": [], "DescriptorName": "Home Care Services"}, {"QualifierName": [], "DescriptorName": "Hospitalization"}, {"QualifierName": [], "DescriptorName": "Host-Pathogen Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Patient Selection"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Platelet Aggregation Inhibitors"}, {"QualifierName": [], "DescriptorName": "Risk Assessment"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}, {"QualifierName": ["drug effects", "pathogenicity"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Time-to-Treatment"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The Authors state they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "D'Amato G, Acanfora L, Delli Paoli L, D'Amato M. Preventive home therapy for symptomatic patients affected by COVID\u201019 and followed by teleconsultations. Multidiscip Respir Med. 2021;16(1):748.", "ArticleIdList": ["PMC7844717", "33532070"]}, {"Citation": "Adiletta G, Baglioni S, Bettoncelli G, et al. Comments on \u201cPreventive home therapy for symptomatic patients affected by COVID\u201019 and followed by teleconsultations\u201d by D'Amato et al. Multidiscip Respir Med. 2021;16(1):757.", "ArticleIdList": ["PMC8056322", "33907625"]}, {"Citation": "Cazzola M, de Novellis V, Bianco A, Rogliani P, Matera MG. Disputes over the production and dissemination of misinformation in the time of COVID\u201019. Respir Med. 2021;182:106380.", "ArticleIdList": ["PMC8006495", "33930690"]}, {"Citation": "Donno DR, Grattagliano I, Rossi A, et al. How to treat COVID\u201019 patients at home in the Italian context: an expert opinion. Infect Dis Rep. 2021;13(1):251\u2010258.", "ArticleIdList": ["PMC8005965", "33804737"]}, {"Citation": "Bonaventura A, Vecchi\u00e9 A, Dagna L, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID\u201019. Nat Rev Immunol. 2021;21(5):319\u2010329.", "ArticleIdList": ["PMC8023349", "33824483"]}, {"Citation": "Albasheer OB, Almutairi HA, Almalki FM, Malaka HM. Massive arterial cerebral thrombosis in a 59\u2010year old female patient with severe COVID\u201019. Cureus. 2021;13(6):e15553.", "ArticleIdList": ["PMC8270568", "34277178"]}, {"Citation": "Ignacio\u2010Ibarra G, Garc\u00eda\u2010Lee MT, Gonz\u00e1lez\u2010\u00c1vila AI, et al. A proposal for the management of COVID\u201019\u2010induced coagulopathy in adults. Gac Med Mex. 2021;157(2):201\u2010206.", "ArticleIdList": ["34270538"]}, {"Citation": "Semeraro N, Colucci M. The prothrombotic state associated with SARS\u2010CoV\u20102 infection: pathophysiological aspects. Mediterr J Hematol Infect Dis. 2021;13(1):e2021045.", "ArticleIdList": ["PMC8265369", "34276914"]}, {"Citation": "Pandolfi S, Chirumbolo S. Home therapy of COVID\u201019 at the earliest may greatly prevent hospitalization. Basic Clin Pharmacol Toxicol. 2021;129(6):395\u2010396. 10.1111/bcpt.13650", "ArticleIdList": ["10.1111/bcpt.13650", "PMC8652880", "34494369"]}, {"Citation": "Galati D, Zanotta S, Capitelli L, Bocchino M. A bird's eye view on the role of dendritic cells in SARS\u2010CoV\u20102 infection: perspectives for immune\u2010based vaccines. Allergy. 2021. 10.1111/all.15004", "ArticleIdList": ["10.1111/all.15004", "PMC8441836", "34245591"]}, {"Citation": "Sepehrinezhad A, Gorji A, Sahab Negah S. SARS\u2010CoV\u20102 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism. Inflammopharmacology. 2021;29(4):1049\u20101059. 10.1007/s10787-021-00845-4", "ArticleIdList": ["10.1007/s10787-021-00845-4", "PMC8266993", "34241783"]}, {"Citation": "Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID\u201019. Signal Transduct Target Ther. 2021;6(1):255.", "ArticleIdList": ["PMC8261820", "34234112"]}, {"Citation": "Cipolloni L, Sessa F, Bertozzi G, et al. Preliminary post\u2010mortem COVID\u201019 evidence of endothelial injury and factor VIII hyperexpression. Diagnostics (Basel). 2020;10(8):575.", "ArticleIdList": ["PMC7460315", "32784826"]}, {"Citation": "Huang L, Wang L, Tan J, Liu H, Ni Y. High\u2010dose vitamin C intravenous infusion in the treatment of patients with COVID\u201019: A protocol for systematic review and meta\u2010analysis. Medicine (Baltimore). 2021;100(19):e25876.", "ArticleIdList": ["PMC8133047", "34106642"]}, {"Citation": "Dwiputra Hernugrahanto K, Novembri Utomo D, Hariman H, et al. Thromboembolic involvement and its possible pathogenesis in COVID\u201019 mortality: lesson from post\u2010mortem reports. Eur Rev Med Pharmacol Sci. 2021;25(3):1670\u20101679.", "ArticleIdList": ["33629337"]}, {"Citation": "Elezkurtaj S, Greuel S, Ihlow J, et al. Causes of death and comorbidities in hospitalized patients with COVID\u201019. Sci Rep. 2021;11(1):4263.", "ArticleIdList": ["PMC7895917", "33608563"]}, {"Citation": "Pandolfi S, Simonetti V, Ricevuti G, Chirumbolo S. Paracetamol in the home treatment of early COVID\u201019 symptoms: a possible foe rather than a friend for elderly patients? J Med Virol. 2021;93(10):5704\u20105706. 10.1002/jmv.27158", "ArticleIdList": ["10.1002/jmv.27158", "PMC8426871", "34170556"]}, {"Citation": "Hashemi SA, Kyani A, Bathaie SZ. The in silico mechanism of hVKOR interaction with acetaminophen and its metabolite, as well as N\u2010acetyl cysteine: caution on application in COVID\u201019 patients. J Biomol Struct Dyn Apr. 2021;20:1\u201012. 10.1080/07391102.2021.1910570", "ArticleIdList": ["10.1080/07391102.2021.1910570", "PMC8074654", "33879035"]}, {"Citation": "Suter F, Consolaro E, Pedroni S, et al. A simple, home\u2010therapy algorithm to prevent hospitalisation for COVID\u201019 patients: A retrospective observational matched\u2010cohort study. EClinicalMedicine. 2021;37:100941.", "ArticleIdList": ["PMC8189543", "34127959"]}, {"Citation": "Reese JT, Coleman B, Chan L, Blau H, Callahan TJ, Cappelletti L, Fontana T, Bradwell KR, Harris NL, Casiraghi E, Valentini G, Karlebach G, Deer R, McMurry JA, Haendel MA, Chute CG, Pfaff E, Moffitt R, Spratt H, Singh J, Mungall CJ, Williams AE, Robinson PN. Cyclooxygenase inhibitor use is associated with increased COVID\u201019 severity. 2021. medRxiv [Preprint]. Apr 20:2021.04.13.21255438."}, {"Citation": "Wastesson JW, Martikainen JE, Zo\u00ebga H, Schmidt M, Karlstad \u00d8, Potteg\u00e5rd A. Trends in use of paracetamol in the Nordic countries. Basic Clin Pharmacol Toxicol. 2018;123(3):301\u2010307.", "ArticleIdList": ["29527817"]}, {"Citation": "Morthorst BR, Erlangsen A, Nordentoft M, Hawton K, Hoegberg LCG, Dalhoff KP. Availability of paracetamol sold over the counter in Europe: a descriptive cross\u2010sectional international survey of pack size restriction. Basic Clin Pharmacol Toxicol. 2018;122(6):643\u2010649.", "ArticleIdList": ["29319222"]}, {"Citation": "Romano S, Galante H, Figueira D, Mendes Z, Rodrigues AT. Time\u2010trend analysis of medicine sales and shortages during COVID\u201019 outbreak: data from community pharmacies. Res Social Adm Pharm. 2021;17(1):1876\u20101881.", "ArticleIdList": ["PMC7245321", "32482587"]}, {"Citation": "Lu X, Zhang L, Du H, et al. SARS\u2010CoV\u20102 infection in children. N Engl J Med. 2020;382(17):1663\u20101665.", "ArticleIdList": ["PMC7121177", "32187458"]}, {"Citation": "Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u20101720.", "ArticleIdList": ["PMC7092819", "32109013"]}, {"Citation": "Lechien JR, Chiesa\u2010Estomba CM, Place S, et al. Clinical and epidemiological characteristics of 1420 European patients with mild\u2010to\u2010moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335\u2010344.", "ArticleIdList": ["PMC7267446", "32352202"]}, {"Citation": "Duong M, Gulmez SE, Salvo F, et al. Usage patterns of paracetamol in France. Br J Clin Pharmacol. 2016;82(2):498\u2010503.", "ArticleIdList": ["PMC4972166", "27059520"]}, {"Citation": "Diener HC, Schneider R, Aicher B. Per\u2010capita consumption of analgesics: a nine\u2010country survey over 20 years. J Headache Pain. 2008;9(4):225\u2010231.", "ArticleIdList": ["PMC3451938", "18618072"]}, {"Citation": "Shader RI. Acetaminophen (paracetamol), COVID\u201019, and misleading conclusions: a commentary. J Clin Psychopharmacol. 2021;41(2):98\u201099.", "ArticleIdList": ["33443969"]}, {"Citation": "Keaveney A, Peters E, Way B. Effects of acetaminophen on risk taking. Soc Cogn Affect Neurosci. 2020;15(7):725\u2010732.", "ArticleIdList": ["PMC7511878", "32888031"]}, {"Citation": "Rodr\u00edguez\u2010Morales AJ, Cardona\u2010Ospina JA, Murillo\u2010Mu\u00f1oz MM. Gastroenterologists, hepatologists, COVID\u201019 and the use of acetaminophen. Clin Gastroenterol Hepatol. 2020;18(9):2142\u20102143.", "ArticleIdList": ["PMC7204721", "32387226"]}, {"Citation": "Peluso L, Abella BS, Ferrer R, Kucher N, Sunde K, Taccone FS. Fever management in COVID\u201019 patients. Minerva Anestesiol. 2021;87(1):1\u20103.", "ArticleIdList": ["33231411"]}, {"Citation": "Robertson JA, Sauer D, Gold JA, Nonas SA. The role of cyclooxygenase\u20102 in mechanical ventilation\u2010induced lung injury. Am J Respir Cell Mol Biol. 2012;47(3):387\u2010394.", "ArticleIdList": ["PMC3488687", "22556158"]}, {"Citation": "Zand Irani A, Borchert G, Craven B, Gibbons H. Flucloxacillin and paracetamol induced pyroglutamic acidosis. BMJ Case Rep. 2021;14(1):e237536.", "ArticleIdList": ["PMC7798777", "33419747"]}, {"Citation": "Hitzing S, B\u00f6ttcher A, Laube M. Metabolische azidose unter paracetamol\u2014eine ungew\u00f6hnliche Nebenwirkung [Metabolic acidosis under acetaminophen intake\u2014an unordinary side effect]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2018;53(10):718\u2010722.", "ArticleIdList": ["30423600"]}, {"Citation": "Mendoza CD, Heard K, Dart RC. Coma, metabolic acidosis and normal liver function in a child with a large serum acetaminophen level. Ann Emerg Med. 2006;48(5):637.", "ArticleIdList": ["17052573"]}, {"Citation": "Steiner AA. Should we let fever run its course in the early stages of COVID\u201019? J R Soc Med. 2020;113(10):407\u2010409.", "ArticleIdList": ["PMC7754817", "32930066"]}, {"Citation": "Hodgman MJ, Garrard AR. A review of acetaminophen poisoning. Crit Care Clin. 2012;28(4):499\u2010516.", "ArticleIdList": ["22998987"]}, {"Citation": "Ortiz\u2010Prado E, Fernandez\u2010Naranjo R, Torres\u2010Berru Y, Lowe R, Torres I. Exceptional prices of medical and other supplies during the COVID\u201019 pandemic in Ecuador. Am J Trop Med Hyg. 2021;1(aop):81\u201087. 10.4269/ajtmh.21-0221", "ArticleIdList": ["10.4269/ajtmh.21-0221", "PMC8274761", "34014837"]}, {"Citation": "O'Keefe JB, Newsom LC, Taylor TH Jr. A survey of provider\u2010reported use and perceived effectiveness of medications for symptom management in telemedicine and outpatient visits for mild COVID\u201019. Infect Dis Ther. 2021;10(2):839\u2010851.", "ArticleIdList": ["PMC7982337", "33748931"]}, {"Citation": "Yousefifard M, Zali A, Zarghi A, Madani Neishaboori A, Hosseini M, Safari S. Non\u2010steroidal anti\u2010inflammatory drugs in management of COVID\u201019; a systematic review on current evidence. Int J Clin Pract. 2020;74(9):e13557.", "ArticleIdList": ["PMC7267090", "32460369"]}, {"Citation": "Knox N, Lee CS, Moon JY, Cohen SP. Pain manifestations of COVID\u201019 and their association with mortality: a multicenter prospective observational study. Mayo Clin Proc. 2021;96(4):943\u2010951.", "ArticleIdList": ["PMC7764470", "33722397"]}, {"Citation": "Williams AM, Langley PG, Osei\u2010Hwediah J, Wendon JA, Hughes RD. Hyaluronic acid and endothelial damage due to paracetamol\u2010induced hepatotoxicity. Liver Int. 2003;23(2):110\u2010115.", "ArticleIdList": ["12654133"]}, {"Citation": "Badmann A, Langsch S, Keogh A, Brunner T, Kaufmann T, Corazza N. TRAIL enhances paracetamol\u2010induced liver sinusoidal endothelial cell death in a Bim\u2010 and Bid\u2010dependent manner. Cell Death Dis. 2012;3(12):e447.", "ArticleIdList": ["PMC3542621", "23254290"]}, {"Citation": "Khanfar A, Al Qaroot B. Could glutathione depletion be the Trojan horse of COVID\u201019 mortality? Eur Rev Med Pharmacol Sci. 2020;24(23):12500\u201012509.", "ArticleIdList": ["33336769"]}, {"Citation": "Espinosa\u2010D\u00edez C, Miguel V, Vallejo S, et al. Role of glutathione biosynthesis in endothelial dysfunction and fibrosis. Redox Biol. 2018;14:88\u201099.", "ArticleIdList": ["PMC5596265", "28888203"]}, {"Citation": "Wrotek S, Soboci\u0144ska J, Koz\u0142owski HM, Pawlikowska M, J\u0119drzejewski T, Dzialuk A. New insights into the role of glutathione in the mechanism of fever. Int J Mol Sci. 2020;21(4):1393.", "ArticleIdList": ["PMC7073131", "32092904"]}, {"Citation": "Dimova S, Hoet PH, Dinsdale D, Nemery B. Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. Int J Biochem Cell Biol. 2005;37(8):1727\u20101737.", "ArticleIdList": ["15878691"]}, {"Citation": "Geddes L. The fever paradox. New Sci. 2020;246(3277):39\u201041. 10.1016/S0262-4079(20)30731-4", "ArticleIdList": ["10.1016/S0262-4079(20)30731-4", "PMC7195085", "32372807"]}, {"Citation": "Egeberg O. The effect of unspecific fever induction on the blood clotting system. Scand J Clin Lab Invest. 1962;14(5):471\u2010474."}, {"Citation": "Zhang J, Huang X, Ding D, Tao Z. Platelet\u2010driven coagulopathy in COVID\u201019 patients: in comparison to seasonal influenza cases. Exp Hematol Oncol. 2021a;10(1):34.", "ArticleIdList": ["PMC8165133", "34059141"]}, {"Citation": "Campbell RA, Boilard E, Rondina MT. Is there a role for the ACE2 receptor in SARS\u2010CoV\u20102 interactions with platelets? J Thromb Haemost. 2021;19(1):46\u201050.", "ArticleIdList": ["PMC7899240", "33119197"]}, {"Citation": "Shen S, Zhang J, Fang Y, et al. SARS\u2010CoV\u20102 interacts with platelets and megakaryocytes via ACE2\u2010independent mechanism. J Hematol Oncol. 2021;14(1):72.", "ArticleIdList": ["PMC8082485", "33926500"]}, {"Citation": "Erlich JM, Talmor DS, Cartin\u2010Ceba R, Gajic O, Kor DJ. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population\u2010based cohort study. Chest. 2011;139(2):289\u2010295.", "ArticleIdList": ["PMC3032365", "20688925"]}, {"Citation": "Munsterhjelm E, Munsterhjelm NM, Niemi TT, Ylikorkala O, Neuvonen PJ, Rosenberg PH. Dose\u2010dependent inhibition of platelet function by acetaminophen in healthy volunteers. Anesthesiology. 2005;103(4):712\u2010717.", "ArticleIdList": ["16192763"]}, {"Citation": "Munsterhjelm E, Niemi TT, Ylikorkala O, Silvanto M, Rosenberg PH. Characterization of inhibition of platelet function by paracetamol and its interaction with diclofenac in vitro. Acta Anaesthesiol Scand. 2005b;49(6):840\u2010846.", "ArticleIdList": ["15954969"]}, {"Citation": "Galliard\u2010Grigioni KS, Fehr M, Reinhart WH. Influence of combinations of acetylsalicylic acid, acetaminophen, and diclofenac on platelet aggregation. Eur J Pharmacol. 2008;595(1\u20133):65\u201068.", "ArticleIdList": ["18700139"]}, {"Citation": "Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase\u20102 inhibitor in man. FASEB j. 2008;22(2):383\u2010390.", "ArticleIdList": ["17884974"]}, {"Citation": "Hamilos M, Petousis S, Parthenakis F. Interaction between platelets and endothelium: from pathophysiology to new therapeutic options. Cardiovasc Diagn Ther. 2018;8(5):568\u2010580.", "ArticleIdList": ["PMC6232347", "30498682"]}, {"Citation": "Sahai A, Bhandari R, Koupenova M, Freedman J, Godwin M, McIntyre T, Chung M, Iskandar JP, Kamran H, Aggarwal A, Kalra A, Bartholomew J, McCrae K, Elbadawi A, Svensson L, Kapadia S, Hariri E, Cameron S. SARS\u2010CoV\u20102 receptors are expressed on human platelets and the effect of aspirin on clinical outcomes in COVID\u201019 patients. 2020. Res Sq [Preprint]. Dec 23:rs.3.rs\u2010119031"}, {"Citation": "Gr\u00e8en K, Drvota V, Vesterqvist O. Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins. 1989;37(3):311\u2010315.", "ArticleIdList": ["2664901"]}, {"Citation": "O'Brien WF, Krammer J, O'Leary TD, Mastrogiannis DS. The effect of acetaminophen on prostacyclin production in pregnant women. Am J Obstet Gynecol. 1993;168(4):1164\u20101169.", "ArticleIdList": ["8475962"]}, {"Citation": "Schwartz JI, Musser BJ, Tanaka WK, et al. Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin. Clin Pharmacol Drug Dev. 2015;4(5):337\u2010345.", "ArticleIdList": ["27137142"]}, {"Citation": "Schildknecht S, Daiber A, Ghisla S, Cohen RA, Bachschmid MM. Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS\u2010activator peroxynitrite. FASEB J. 2008;22(1):215\u2010224.", "ArticleIdList": ["17724253"]}, {"Citation": "Schmelzle M, Splith K, Andersen LW, et al. Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury. Transplantation. 2013;95(1):63\u201069.", "ArticleIdList": ["PMC3536489", "23232366"]}, {"Citation": "Zahran AM, El\u2010Badawy O, Ali WA, Mahran ZG, Mahran EEMO, Rayan A. Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID\u201019; relation to cancer. PLoS ONE. 2021;16(2):e0246806.", "ArticleIdList": ["PMC7899358", "33617530"]}, {"Citation": "Czervionke RL, Smith JB, Fry GL, Hoak JC, Haycraft DL. Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence. J Clin Invest. 1979;63(5):1089\u20101092.", "ArticleIdList": ["PMC372053", "376548"]}, {"Citation": "Parks WM, Hoak JC, Czervionke RL. Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis. J Pharmacol Exp Ther. 1981;219(2):415\u2010419.", "ArticleIdList": ["7026767"]}, {"Citation": "Wessels DA, Hempel SL. Ibuprofen protects human endothelial cell prostaglandin H synthase from hydrogen peroxide. Am J Physiol. 1996;271(6 Pt 1):C1879\u2010C1886.", "ArticleIdList": ["8997188"]}, {"Citation": "Gorudko IV, Shamova EV, Shishlo LM, et al. Glutathione\u2010dependent regulation of platelet aggregation with neutrophils and tumor cells. Biofizika. 2012;57(1):93\u201098.", "ArticleIdList": ["22567914"]}, {"Citation": "Essex DW, Li M. Redox control of platelet aggregation. Biochemistry. 2003;42(1):129\u2010136.", "ArticleIdList": ["12515547"]}, {"Citation": "Essex DW, Li M, Feinman RD, Miller A. Platelet surface glutathione reductase\u2010like activity. Blood. 2004;104(5):1383\u20101385.", "ArticleIdList": ["15142878"]}, {"Citation": "Ball C, Vijayan KV, Nguyen T, et al. Glutathione regulates integrin alpha (IIb)beta(3)\u2010mediated cell adhesion under flow conditions. Thromb Haemost. 2008;100(5):857\u2010863.", "ArticleIdList": ["18989530"]}, {"Citation": "Kozer E, Evans S, Barr J, et al. Glutathione, glutathione\u2010dependent enzymes and antioxidant status in erythrocytes from children treated with high\u2010dose paracetamol. Br J Clin Pharmacol. 2003;55(3):234\u2010240.", "ArticleIdList": ["PMC1884208", "12630972"]}, {"Citation": "Ekim M, Sekeroglu MR, Balahoroglu R, Ozkol H, Ekim H. Roles of the oxidative stress and ADMA in the development of deep venous thrombosis. Biochem Res Int. 2014;2014:703128.", "ArticleIdList": ["PMC4003758", "24818025"]}, {"Citation": "Rybka J, Kupczyk D, K\u0119dziora\u2010Kornatowska K, et al. Glutathione\u2010related antioxidant defense system in elderly patients treated for hypertension. Cardiovasc Toxicol. 2011;11(1):1\u20109.", "ArticleIdList": ["PMC3035775", "21140238"]}, {"Citation": "Bartolini D, Stabile AM, Bastianelli S, et al. SARS\u2010CoV2 infection impairs the metabolism and redox function of cellular glutathione. Redox Biol. 2021;45:102041.", "ArticleIdList": ["PMC8190457", "34146958"]}, {"Citation": "Polonikov A. Endogenous deficiency of glutathione as the most likely cause of serious manifestations and death in COVID\u201019 patients. ACS Infect Dis. 2020;6(7):1558\u20101562.", "ArticleIdList": ["32463221"]}, {"Citation": "Zhang Y, Guo R, Kim SH, et al. SARS\u2010CoV\u20102 hijacks folate and one\u2010carbon metabolism for viral replication. Nat Commun. 2021b;12(1):1676. 10.1038/s41467-021-21903-z", "ArticleIdList": ["10.1038/s41467-021-21903-z", "PMC7960988", "33723254"]}, {"Citation": "Rousar T, Pa\u0159\u00edk P, Kucera O, Bartos M, \u010cervinkov\u00e1 Z. Glutathione reductase is inhibited by acetaminophen\u2010glutathione conjugate in vitro. Physiol Res. 2010;59(2):225\u2010232.", "ArticleIdList": ["19537930"]}, {"Citation": "McIntyre BA, Philp RB, Inwood MJ. Effect of ibuprofen on platelet function in normal subjects and hemophiliac patients. Clin Pharmacol Ther. 1978;24(5):616\u2010621.", "ArticleIdList": ["699486"]}, {"Citation": "Ikeda Y. The effect of ibuprofen on platelet function in vivo. Keio J Med. 1977;26(4):213\u2010222.", "ArticleIdList": ["618087"]}, {"Citation": "De la Cruz JP, Reyes JJ, Ruiz\u2010Moreno MI, Lopez\u2010Villodres JA, Jebrouni N, Gonzalez\u2010Correa JA. Differences in the in vitro antiplatelet effect of dexibuprofen, ibuprofen, and flurbiprofen in human blood. Anesth Analg. 2010;111(6):1341\u20101346.", "ArticleIdList": ["21048099"]}, {"Citation": "Chakraborty K, Khan GA, Banerjee P, Ray U, Sinha AK. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Platelets. 2003;14(7\u20138):421\u2010427.", "ArticleIdList": ["14713511"]}, {"Citation": "Kelleni MT. NSAIDs/nitazoxanide/azithromycin repurposed for COVID\u201019: potential mitigation of the cytokine storm interleukin\u20106 amplifier via immunomodulatory effects. Expert Rev Anti Infect Ther Jun. 2021a;15:1\u20105.", "ArticleIdList": ["PMC8220441", "34088250"]}, {"Citation": "Valenzuela R, Pedrosa MA, Garrido\u2010Gil P, et al. Interactions between ibuprofen, ACE2, renin\u2010angiotensin system, and spike protein in the lung. Implications for COVID\u201019. Clin Transl Med. 2021;11(4):e371.", "ArticleIdList": ["PMC8019581", "33931961"]}, {"Citation": "Moore N, Carleton B, Blin P, Bosco\u2010Levy P, Droz C. Does ibuprofen worsen COVID\u201019? Drug Saf. 2020a;43(7):611\u2010614.", "ArticleIdList": ["PMC7287029", "32529474"]}, {"Citation": "Jamerson BD, Haryadi TH. The use of ibuprofen to treat fever in COVID\u201019: a possible indirect association with worse outcome? Med Hypotheses. 2020;144:109880.", "ArticleIdList": ["PMC7247463", "32505846"]}, {"Citation": "Mitchell JA, Lucas R, Vojnovic I, Hasan K, Pepper JR, Warner TD. Stronger inhibition by nonsteroid anti\u2010inflammatory drugs of cyclooxygenase\u20101 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events. FASEB J. 2006;20(14):2468\u20102475.", "ArticleIdList": ["17142796"]}, {"Citation": "Kutti Sridharan G, Kotagiri R, Chandiramani VH, et al. COVID\u201019 and avoiding ibuprofen. How good is the evidence? Am J Ther. 2020;27(4):e400\u2010e402.", "ArticleIdList": ["PMC7242088", "32366740"]}, {"Citation": "Pergolizzi JV Jr, Varrassi G, Magnusson P, et al. COVID\u201019 and NSAIDS: a narrative review of knowns and unknowns. Pain Ther. 2020;9(2):353\u2010358.", "ArticleIdList": ["PMC7245573", "32447629"]}, {"Citation": "Abu Esba LC, Alqahtani RA, Thomas A, Shamas N, Alswaidan L, Mardawi G. Ibuprofen and NSAID use in COVID\u201019 infected patients is not associated with worse outcomes: a prospective cohort study. Infect Dis Ther. 2021;10(1):253\u2010268.", "ArticleIdList": ["PMC7604230", "33135113"]}, {"Citation": "Poutoglidou F, Saitis A, Kouvelas D. Ibuprofen and COVID\u201019 disease: separating the myths from facts. Expert Rev Respir Med. 2021;15(8):979\u2010983.", "ArticleIdList": ["34196258"]}, {"Citation": "Sim\u00f5es e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. ACE2, angiotensin\u2010(1\u20107) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol. 2013;169(3):477\u2010492.", "ArticleIdList": ["PMC3682698", "23488800"]}, {"Citation": "Santos RAS, Sampaio WO, Alzamora AC, et al. The ACE2/angiotensin\u2010(1\u20107)/MAS axis of the renin\u2010angiotensin system: focus on angiotensin\u2010(1\u20107). Physiol Rev. 2018;98(1):505\u2010553.", "ArticleIdList": ["PMC7203574", "29351514"]}, {"Citation": "Franco R, Lillo A, Rivas\u2010Santisteban R, et al. Functional complexes of angiotensin\u2010converting enzyme 2 and renin\u2010angiotensin system receptors: expression in adult but not fetal lung tissue. Int J Mol Sci. 2020;21(24):9602.", "ArticleIdList": ["PMC7766085", "33339432"]}, {"Citation": "Deshotels MR, Xia H, Sriramula S, Lazartigues E, Filipeanu CM. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor\u2010dependent mechanism. Hypertension. 2014;64(6):1368\u20101375.", "ArticleIdList": ["PMC4231883", "25225202"]}, {"Citation": "Xu J, Sriramula S, Xia H, et al. Clinical relevance and role of neuronal AT1 receptors in ADAM17\u2010mediated ACE2 shedding in neurogenic hypertension. Circ Res. 2017;121(1):43\u201055.", "ArticleIdList": ["PMC5507353", "28512108"]}, {"Citation": "Kashiwagi E, Shiota M, Yokomizo A, Inokuchi J, Uchiumi T, Naito S. EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer. Prostate Cancer Prostatic Dis. 2014;17(1):10\u201017.", "ArticleIdList": ["24518515"]}, {"Citation": "Saheb Sharif\u2010Askari N, Saheb Sharif\u2010Askari F, Mdkhana B, et al. Effect of common medications on the expression of SARS\u2010CoV\u20102 entry receptors in liver tissue. Arch Toxicol. 2020;94(12):4037\u20104041.", "ArticleIdList": ["PMC7430937", "32808185"]}, {"Citation": "Chen JS, Alfajaro MM, Wei J, Chow RD, Filler RB, Eisenbarth SC, Wilen CB. Cyclooxgenase\u20102 is induced by SARS\u2010CoV\u20102 infection but does not affect viral entry or replication. 2020. bioRxiv [Preprint]. Sep 25:2020.09.24.312769. 10.1101/2020.09.24.312769", "ArticleIdList": ["10.1101/2020.09.24.312769"]}, {"Citation": "Kohlstedt K, Brandes RP, M\u00fcller\u2010Esterl W, Busse R, Fleming I. Angiotensin\u2010converting enzyme is involved in outside\u2010in signaling in endothelial cells. Circ Res. 2004;94(1):60\u201067.", "ArticleIdList": ["14615289"]}, {"Citation": "Kohlstedt K, Busse R, Fleming I. Signaling via the angiotensin\u2010converting enzyme enhances the expression of cyclooxygenase\u20102 in endothelial cells. Hypertension. 2005;45(1):126\u2010132.", "ArticleIdList": ["15569856"]}, {"Citation": "Martini WZ, Rodriguez CM, Deguzman R, et al. Dose responses of ibuprofen in vitro on platelet aggregation and coagulation in human and pig blood samples. Mil Med. 2016;181(5 Suppl):111\u2010116.", "ArticleIdList": ["27168560"]}, {"Citation": "White WB, Faich G, Whelton A, et al. Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase\u20102 specific inhibitor, versus ibuprofen or diclofenac. Am J Cardiol. 2002;89(4):425\u2010430.", "ArticleIdList": ["11835924"]}, {"Citation": "Arjomandi Rad A, Vardanyan R, Tas NR. Ibuprofen and thromboembolism in SARS\u2010COV2. J Thromb Haemost. 2020;18(9):2425\u20102427.", "ArticleIdList": ["PMC7276881", "32415902"]}, {"Citation": "Cui S, Chen S, Ke L. Reply to \u201cIbuprofen and thromboembolism in SARS\u2010COV2\u201d. J Thromb Haemost. 2020;18(9):2427\u20102428.", "ArticleIdList": ["PMC7283706", "32470154"]}, {"Citation": "Moore N. No arguments for extra risk from ibuprofen in SARS\u2010COV2 infection. Therapie. 2020b;75(5):513\u2010514.", "ArticleIdList": ["PMC7836811", "32829912"]}, {"Citation": "Terrier O, Dilly S, Pizzorno A, et al. Antiviral properties of the NSAID drug naproxen targeting the nucleoprotein of SARS\u2010CoV\u20102 coronavirus. Molecules. 2021;26(9):2593.", "ArticleIdList": ["PMC8124269", "33946802"]}, {"Citation": "Gurbel PA, Bliden KP, Zhu J, et al. Thromboxane inhibition during concurrent therapy with low\u2010dose aspirin and over\u2010the\u2010counter naproxen sodium. J Thromb Thrombolysis. 2018;45(1):18\u201026.", "ArticleIdList": ["29198079"]}, {"Citation": "Scalise M, Indiveri C. Repurposing nimesulide, a potent inhibitor of the B0AT1 subunit of the SARS\u2010CoV\u20102 receptor, as a therapeutic adjuvant of COVID\u201019. SLAS Discov. 2020;25(10):1171\u20101173.", "ArticleIdList": ["PMC8960182", "32500793"]}, {"Citation": "Kumar S, Singh B, Kumari P, et al. Identification of multipotent drugs for COVID\u201019 therapeutics with the evaluation of their SARS\u2010CoV2 inhibitory activity. Comput Struct Biotechnol J. 2021;19:1998\u20102017.", "ArticleIdList": ["PMC8025584", "33841751"]}, {"Citation": "Amici C, Di Caro A, Ciucci A, et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther. 2006;11(8):1021\u20101030.", "ArticleIdList": ["17302372"]}, {"Citation": "Reynolds AE, Enquist LW. Biological interactions between herpesviruses and cyclooxygenase enzymes. Rev Med Virol. 2006;16(6):393\u2010403.", "ArticleIdList": ["17006962"]}, {"Citation": "Schr\u00f6er J, Shenk T. Inhibition of cyclooxygenase activity blocks cell\u2010to\u2010cell spread of human cytomegalovirus. Proc Natl Acad Sci U S A. 2008;105(49):19468\u201019473.", "ArticleIdList": ["PMC2614784", "19033472"]}, {"Citation": "Bahrami H, Daryani NE, Haghpanah B, et al. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo\u2010controlled trial. Am J Gastroenterol. 2005;100(4):856\u2010861.", "ArticleIdList": ["15784032"]}, {"Citation": "\nNapolitano F, Gambardella G, Carrella D, Gao X, di Bernardo D. Computational drug repositioning and elucidation of mechanism of action of compounds against SARS\u2010COV\u20102. 2020. https://arxiv.org/abs/2004.07697v2\n"}, {"Citation": "Raghav N, Kamboj RC, Singh H. Effect of some steroidal & non\u2010steroidal anti\u2010inflammatory drugs on purified goat brain cathepsin L. Indian J Med Res. 1993;98:188\u2010192.", "ArticleIdList": ["8262580"]}, {"Citation": "Xu T, Gao X, Wu Z, Selinger DW, Zhou Z. Indomethacin has a potent antiviral activity against SARS\u2010COV\u20102 in vitro and canine coronavirus in vivo. BioRXiv (preprint) April 2020. 10.1101/2020.04.01.017624", "ArticleIdList": ["10.1101/2020.04.01.017624"]}, {"Citation": "Russell B, Moss C, George G, et al. Associations between immune\u2010suppressive and stimulating drugs and novel COVID\u201019\u2010a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022.", "ArticleIdList": ["PMC7105343", "32256705"]}, {"Citation": "Alkotaji M, Al\u2010Zidan RN. Indomethacin: can it counteract bradykinin effects in COVID\u201019 patients? Curr Pharmacol Rep. 2021;22(3):1\u20105.", "ArticleIdList": ["PMC8062113", "33907665"]}, {"Citation": "Cochener B, Kling F, Savary\u2010Le Floch G, Colin J. Indom\u00e9thacine (Indocollyre) versus Diclof\u00e9nac (Voltar\u00e8ne) sur la douleur post\u2010photoablation excimer de surface [Indomethacin (indocollyre) versus diclofenac (voltarene) for the control of pain following excimer photoablation]. J Fr Ophtalmol. 2000;23(6):555\u2010562. French.", "ArticleIdList": ["10880920"]}, {"Citation": "Prasher P, Sharma M, Gunupuru R. Targeting cyclooxygenase enzyme for the adjuvant COVID\u201019 therapy. Drug Dev Res. 2021;82(4):469\u2010473.", "ArticleIdList": ["PMC8013002", "33496060"]}, {"Citation": "Malikiwi A, Roufaeil C, Tan K, Sehgal A. Indomethacin vs ibuprofen: comparison of efficacy in the setting of conservative therapeutic approach. Eur J Pediatr. 2015;174(5):615\u2010620.", "ArticleIdList": ["25344763"]}, {"Citation": "Kelleni MT. Early use of non\u2010steroidal anti\u2010inflammatory drugs in COVID\u201019 might reverse pathogenesis, prevent complications and improve clinical outcomes. Biomed Pharmacother. 2021b;133:110982.", "ArticleIdList": ["PMC7640889", "33197762"]}, {"Citation": "Chen JS, Alfajaro MM, Chow RD, et al. Non\u2010steroidal anti\u2010inflammatory drugs dampen the cytokine and antibody response to SARS\u2010CoV\u20102 infection. J Virol. 2021;95(7). e00014\u2013e00021", "ArticleIdList": ["PMC8092681", "33441348"]}, {"Citation": "Ravichandran R, Purna P, Vijayaragavan S, Kalavakollu RT, Gaidhane S, Kumar RK. Efficacy and safety of indomethacin in COVID\u201019 patients. 2020. medRxiv 12.14.20245266. 10.1101/2020.12.14.20245266", "ArticleIdList": ["10.1101/2020.12.14.20245266"]}, {"Citation": "Mehta N, Mazer\u2010Amirshahi M, Alkindi N, Pourmand A. Pharmacotherapy in COVID\u201019; a narrative review for emergency providers. Am J Emerg Med. 2020;38(7):1488\u20101493.", "ArticleIdList": ["PMC7158837", "32336586"]}, {"Citation": "Sun F, Zhang Y, Li Q. Therapeutic mechanisms of ibuprofen, prednisone and betamethasone in osteoarthritis. Mol Med Rep. 2017;15(2):981\u2010987.", "ArticleIdList": ["28035387"]}, {"Citation": "Grosser T. The pharmacology of selective inhibition of COX\u20102. Thromb Haemost. 2006;96(4):393\u2010400.", "ArticleIdList": ["17003913"]}, {"Citation": "Dapino P, Ottonello L, Dallegri F. The anti\u2010inflammatory drug nimesulide inhibits neutrophil adherence to and migration across monolayers of cytokine\u2010activated endothelial cells. Respiration. 1994;61(6):336\u2010341.", "ArticleIdList": ["7824814"]}, {"Citation": "Baghaki S, Yalcin CE, Baghaki HS, Aydin SY, Daghan B, Yavuz E. COX2 inhibition in the treatment of COVID\u201019: review of literature to propose repositioning of celecoxib for randomized controlled studies. Int J Infect Dis. 2020;101:29\u201032.", "ArticleIdList": ["PMC7525269", "33007455"]}, {"Citation": "Garc\u00eda\u2010\u00c1lvarez JL, Garc\u00eda\u2010Vigil JL. Guidelines for clinical management of SARS\u2010CoV\u20102 infection. Gac Med Mex. 2020;156(6):576\u2010583.", "ArticleIdList": ["33877121"]}, {"Citation": "Akhter J, Qu\u00e9rom\u00e8s G, Pillai K, et al. The combination of bromelain and acetylcysteine (BromAc) synergistically inactivates SARS\u2010CoV\u20102. Viruses. 2021;13(3):425.", "ArticleIdList": ["PMC7999995", "33800932"]}, {"Citation": "Liu Q, Huang N, Li A, et al. Effect of low\u2010dose aspirin on mortality and viral duration of the hospitalized adults with COVID\u201019. Medicine (Baltimore). 2021;100(6):e24544.", "ArticleIdList": ["PMC7886487", "33578548"]}, {"Citation": "Osborne TF, Veigulis ZP, Arreola DM, Mahajan SM, R\u00f6\u00f6sli E, Curtin CM. Association of mortality and aspirin prescription for COVID\u201019 patients at the Veterans Health Administration. PLoS ONE. 2021;16(2):e0246825.", "ArticleIdList": ["PMC7877611", "33571280"]}, {"Citation": "Martha JW, Pranata R, Lim MA, Wibowo A, Akbar MR. Active prescription of low\u2010dose aspirin during or prior to hospitalization and mortality in COVID\u201019: A systematic review and meta\u2010analysis of adjusted effect estimates. Int J Infect Dis. 2021;108:6\u201012.", "ArticleIdList": ["PMC8123385", "34000418"]}, {"Citation": "Srivastava R, Kumar A. Use of aspirin in reduction of mortality of COVID\u201019 patients: a metanalysis. Int J Clin Pract. 2021;e14515.", "ArticleIdList": ["PMC8420464", "34118111"]}, {"Citation": "Violi F, Cammisotto V, Pignatelli P. Thrombosis in Covid\u201019 and non\u2010Covid\u201019 pneumonia: role of platelets. Platelets. 2021;7:1\u20109. 10.1080/09537104.2021.1936478", "ArticleIdList": ["10.1080/09537104.2021.1936478", "PMC8204311", "34097572"]}, {"Citation": "Pan D, Ip A, Zhan S, et al. Pre\u2010hospital antiplatelet medication use on COVID\u201019 disease severity. Heart Lung. 2021;50(5):618\u2010621.", "ArticleIdList": ["PMC8156906", "34090177"]}, {"Citation": "Chirumbolo S. Nutraceuticals and dietary supplements should not be used to treat COVID\u201019 as pharmaceuticals. Nutrition. 2021, in press;111494.", "ArticleIdList": ["PMC8451977", "34656407"]}, {"Citation": "Minich DM, Brown BI. A review of dietary (phyto)nutrients for glutathione support. Nutrients. 2019;11(9):2073.", "ArticleIdList": ["PMC6770193", "31484368"]}, {"Citation": "Hall K, Mfone F, Shallcross M, Pathak V. Review of pharmacotherapy trialed for management of the coronavirus disease\u201019. Eur J Med. 2021;53(2):137\u2010143.", "ArticleIdList": ["PMC8184028", "34177298"]}, {"Citation": "Chirumbolo S, Valdenassi L, Simonetti V, et al. Insights on the mechanisms of action of ozone in the medical therapy against COVID\u201019. Int Immunopharmacol. 2021;96:107777.", "ArticleIdList": ["PMC8112288", "34020394"]}, {"Citation": "Franzini M, Valdenassi L, Ricevuti G, et al. Oxygen\u2010ozone (O2\u2010O3) immunoceutical therapy for patients with COVID\u201019. Preliminary evidence reported. Int Immunopharmacol. 2020;88:106879.", "ArticleIdList": ["PMC7414302", "32795898"]}, {"Citation": "Di Pierro F, Iqtadar S, Khan A, et al. Potential clinical benefits of quercetin in the early stage of covid\u201019: results of a second, pilot, randomized, controlled and open\u2010label clinical trial. Int J Gen Med. 2021;14:2807\u20102816.", "ArticleIdList": ["PMC8238537", "34194240"]}, {"Citation": "Kandeil A, Mostafa A, Kutkat O, et al. Bioactive polyphenolic compounds showing strong antiviral activities against severe acute respiratory syndrome coronavirus 2. Pathogens. 2021;10(6):758.", "ArticleIdList": ["PMC8232731", "34203977"]}, {"Citation": "Alesci A, Aragona M, Cicero N, Lauriano ER. Can nutraceuticals assist treatment and improve covid\u201019 symptoms? Nat Prod Res. 2021;5:1\u201020.", "ArticleIdList": ["33949266"]}, {"Citation": "Ho P, Zheng JQ, Wu CC, et al. Perspective adjunctive therapies for COVID\u201019: beyond antiviral therapy. Int J Med Sci. 2021;18(2):314\u2010324.", "ArticleIdList": ["PMC7757136", "33390800"]}, {"Citation": "Taher A, Lashgari M, Sedighi L, Rahimi\u2010Bashar F, Poorolajal J, Mehrpooya M. A pilot study on intravenous N\u2010Acetylcysteine treatment in patients with mild\u2010to\u2010moderate COVID19\u2010associated acute respiratory distress syndrome. Pharmacol Rep. 2021;10(6):1\u201010. 10.1007/s43440-021-00296-2", "ArticleIdList": ["10.1007/s43440-021-00296-2", "PMC8191712", "34114174"]}, {"Citation": "Shi Z, Puyo CA. N\u2010acetylcysteine to combat COVID\u201019: an evidence review. Ther Clin Risk Manag. 2020;16:1047\u20101055.", "ArticleIdList": ["PMC7649937", "33177829"]}, {"Citation": "De Flora S, Balansky R, La Maestra S. Rationale for the use of N\u2010acetylcysteine in both prevention and adjuvant therapy of COVID\u201019. FASEB J. 2020;34(10):13185\u201013193. 10.1096/fj.202001807", "ArticleIdList": ["10.1096/fj.202001807", "PMC7436914", "32780893"]}, {"Citation": "Poe FL, Corn J. N\u2010Acetylcysteine: a potential therapeutic agent for SARS\u2010CoV\u20102. Med Hypotheses. 2020;143:109862.", "ArticleIdList": ["PMC7261085", "32504923"]}, {"Citation": "Zhang R, Qi J, Zhou M, et al. Upregulation of Nrf\u20102 attenuates oxidative stress\u2010induced complement activation\u2010associated endothelial injury and apoptosis in transplant\u2010associated thrombotic microangiopathy. Transplant Cell Ther. 2021c;S2666\u20106367(21):01002.", "ArticleIdList": ["34174470"]}, {"Citation": "Atefi N, Behrangi E, Mozafarpoor S, Seirafianpour F, Peighambari S, Goodarzi A. N\u2010acetylcysteine and coronavirus disease 2019: may it work as a beneficial preventive and adjuvant therapy? A comprehensive review study. J Res Med Sci. 2020;25:109.", "ArticleIdList": ["PMC8019127", "33824674"]}, {"Citation": "Consolaro E, Suter F, Rubis N, Nurse R, Pedroni S, Moroni C, Past\u00f2 E, Paganini MV, Pravettoni G, Cantarelli U, Perico N, Perna A, Peracchi TS, Ruggenenti P, Remuzzi G. A home\u2010treatment algorithmbased on anti\u2010inflammatory drugs to prevcent hospitalization of patients with early COVID\u201019. A matched\u2010cohort study (COVER 2). MedRXiv Oct 1 2021. 10.1101/2021.09.29.21264298", "ArticleIdList": ["10.1101/2021.09.29.21264298", "PMC9073076", "35530041"]}, {"Citation": "Kelleni MT. NSAIDs/nitazoxanide/azithromycin immunomodulatory protocol used in adult, geriatric, pediatric, pregnant, and immunocompromised COVID\u201019 patients: a real\u2010world experience. Canad J Medicine. 2021;3(3):121\u2010143."}, {"Citation": "Kow CS, Hasan SS. Use of low\u2010molecular\u2010weight heparin in COVID\u201019 patients. J Vasc Surg Venous Lymphat Disord. 2020;8(5):900\u2010901.", "ArticleIdList": ["PMC7297673", "32561464"]}, {"Citation": "di Micco P, Tufano A, Cardillo G, et al. The impact of risk\u2010adjusted heparin regimens on the outcome of patients with COVID\u201019 Infection. A prospective cohort study. Viruses. 2021;13(9):1720.", "ArticleIdList": ["PMC8473366", "34578301"]}, {"Citation": "Chirumbolo S, Simonetti V, Franzini M, Valdenassi L, Bertossi D, Pandolfi S. Estimating coronavirus disease 2019 (COVID\u201019)\u2010caused deaths in hospitals and healthcare units: do hospital\u2010acquired infections play a role? Comments with a proposal. Infect Control Hosp Epidemiol Mar. 2021b;19:1\u20102.", "ArticleIdList": ["PMC8047388", "33736720"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "3"}, {"Year": "2021", "Month": "9", "Day": "21"}, {"Year": "2021", "Month": "11", "Day": "16"}, {"Year": "2021", "Month": "11", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "23", "Hour": "6", "Minute": "56"}, {"Year": "2021", "Month": "12", "Day": "2"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34811895", "PMC9011697", "10.1111/bcpt.13690"]}}], "PubmedBookArticle": []}